Latest Catalys Pacific, LLC Stock Portfolio

$229Million | No. of Holdings #2

About Catalys Pacific, LLC and 13F Hedge Fund Stock Holdings

On 2026-08-05, the fund reported it's updated stock portfolio. In the 13F Holdings report, Catalys Pacific, LLC reported an equity portfolio of $229.5 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Catalys Pacific, LLC are , PHAT. The fund has invested 92.9% of it's portfolio in MINERALYS THERAPEUTICS, INC. and 7.1% of portfolio in PHATHOM PHARMACEUTICALS, INC. <br><br>
Catalys Pacific, LLC Equity Portfolio Value
Last Reported on: 05 Aug, 2026
$229Million
  as of Aug 05, 2026

Catalys Pacific, LLC Annual Return Estimates Vs S&P 500

  • Performance

New Buys

No new stocks were added by Catalys Pacific, LLC

Additions

No additions were made to existing positions by Catalys Pacific, LLC

Reductions

None of the existing positions were reduced by Catalys Pacific, LLC

Sold off

None of the stocks were completely sold off by Catalys Pacific, LLC

Sector Distribution

  • Others
  • Healthcare
Sector%
Others92.9
Healthcare7.1

Market Cap. Distribution

  • UNALLOCATED
  • SMALL-CAP
Category%
UNALLOCATED92.9
SMALL-CAP7.1

Stocks belong to which Index?

  • Others
  • RUSSELL 2000
Index%
Others92.9
RUSSELL 20007.1
Top 5 Winners (%)%
Top 5 Winners ($)$
Top 5 Losers (%)%
PHAT
phathom pharmaceuticals, inc.
-2.3 %
mineralys therapeutics, inc.
-0.4 %
Top 5 Losers ($)$
mineralys therapeutics, inc.
-0.9 M
PHAT
phathom pharmaceuticals, inc.
-0.4 M

Catalys Pacific, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Catalys Pacific, LLC

$229.45MTotal Value
2.00Positions
05 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Catalys Pacific, LLC, last reported on 05 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
Com
Mineralys Therapeutics, Inc.

Mineralys Therapeutics, Inc.

Catalys Pacific, LLC's holding in Mineralys Therapeutics, Inc. over time
92.94%7,903,840
$213.25M
92.94%
unchanged 0 percentunchanged